ID
25657
Beskrivning
Study ID: 101468/228 Clinical Study ID: 101468/228 Study Title:A two year Phase IIIb randomised, multicenter, double-blind, SINEMET controlled, parallel group, flexible dose study, to assess the effectiveness of controlled release ropinirole add-on therapy to L-dopa at increasing the time to onset of dyskinesia in Parkinson's disease subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00363727 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Dyskinesias; Parkinson Disease; Parkinson's Disease Study part: Fatigue/sleep Scales (ESS/PDSS).
Nyckelord
Versioner (2)
- 2017-08-12 2017-08-12 -
- 2017-09-08 2017-09-08 -
Uppladdad den
8 september 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Fatigue/sleep Scales (ESS/PDSS) GSK study Dyskinesia in Parkinson's disease NCT00363727
Fatigue/sleep Scales (ESS/PDSS) GSK study Dyskinesia in Parkinson's disease NCT00363727
Similar models
Fatigue/sleep Scales (ESS/PDSS) GSK study Dyskinesia in Parkinson's disease NCT00363727
C0678257 (UMLS CUI [1,2])
C0681889 (UMLS CUI [1,2])